SE7703721L - Forfarande for framstellning av hexahydroprimidinforeningar med terapeutisk verkan - Google Patents

Forfarande for framstellning av hexahydroprimidinforeningar med terapeutisk verkan

Info

Publication number
SE7703721L
SE7703721L SE7703721A SE7703721A SE7703721L SE 7703721 L SE7703721 L SE 7703721L SE 7703721 A SE7703721 A SE 7703721A SE 7703721 A SE7703721 A SE 7703721A SE 7703721 L SE7703721 L SE 7703721L
Authority
SE
Sweden
Prior art keywords
hexahydroprimide
compounds
procedure
preparation
therapeutic effect
Prior art date
Application number
SE7703721A
Other languages
English (en)
Swedish (sv)
Inventor
O Miyashita
K Matsumura
H Shimadzu
N Hashimoto
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3665376A external-priority patent/JPS52118480A/ja
Priority claimed from JP12993276A external-priority patent/JPS5353672A/ja
Priority claimed from JP14679576A external-priority patent/JPS5371086A/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of SE7703721L publication Critical patent/SE7703721L/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C273/00Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C273/18Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
    • C07C273/1854Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas by reactions not involving the formation of the N-C(O)-N- moiety
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/553Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE7703721A 1976-03-31 1977-03-30 Forfarande for framstellning av hexahydroprimidinforeningar med terapeutisk verkan SE7703721L (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3665376A JPS52118480A (en) 1976-03-31 1976-03-31 Synthesis of uracil derivatives
JP12993276A JPS5353672A (en) 1976-10-27 1976-10-27 Fluoropyrimidine deivatives
JP14679576A JPS5371086A (en) 1976-12-06 1976-12-06 Preparation of uracil derivs.

Publications (1)

Publication Number Publication Date
SE7703721L true SE7703721L (sv) 1977-10-01

Family

ID=27289176

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7703721A SE7703721L (sv) 1976-03-31 1977-03-30 Forfarande for framstellning av hexahydroprimidinforeningar med terapeutisk verkan

Country Status (18)

Country Link
US (1) US4329460A (nl)
CA (1) CA1081226A (nl)
CH (1) CH632748A5 (nl)
DD (2) DD137353A5 (nl)
DE (1) DE2714392A1 (nl)
DK (1) DK142029B (nl)
ES (1) ES469098A1 (nl)
FI (1) FI770904A (nl)
FR (1) FR2346337A1 (nl)
GB (1) GB1546346A (nl)
GR (1) GR68935B (nl)
NL (1) NL7703541A (nl)
NO (1) NO771124L (nl)
PH (1) PH14553A (nl)
PL (1) PL106917B1 (nl)
PT (1) PT66374B (nl)
SE (1) SE7703721L (nl)
SU (1) SU795467A3 (nl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57179188A (en) * 1981-04-28 1982-11-04 Shionogi & Co Ltd 5-fluorouracil derivative
DK167280B1 (da) * 1985-03-20 1993-10-04 Ciba Geigy Ag 3-aryluracilderivater, fremgangsmaade til fremstilling deraf, ukrudtsbekaempelsesmidler indeholdende disse derivater samt anvendelsen af derivaterne til ukrudtsbekaempelse
US4669081A (en) * 1986-02-04 1987-05-26 Raytheon Company LSI fault insertion
US4816585A (en) * 1987-03-05 1989-03-28 Olin Corporation Tetraalkylpiperidinyl substituted uracil derivatives and their use as ultraviolet light stabilizers
US4904714A (en) * 1987-10-02 1990-02-27 Olin Corporation Synthetic resin composition and its method of use
US4920126A (en) * 1988-05-10 1990-04-24 Uniroyal Chemical Ltd/Uniroyal Chemical Ltee Barbituric acid derivative and treatment of leukemia and tumors therewith
US5312919A (en) * 1992-06-12 1994-05-17 Baylor Research Institute Photooxidation products and derivatives thereof of merocyanine-540, their preparation and uses

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3277092A (en) * 1963-05-02 1966-10-04 Hoffmann La Roche 5, 6-substituted dihydro-5-fluoropyrimidines
US3221010A (en) * 1963-05-02 1965-11-30 Hoffmann La Roche 5,6-substituted dihydro-5-fluoropyrimidine nucleosides
US3201387A (en) * 1963-09-18 1965-08-17 Heidelberger Charles 5-trifluoromethyluracil, derivatives thereof, and processes for preparing the same
US3360523A (en) * 1964-06-17 1967-12-26 Du Pont 3, 5, 6-substituted hydrouracils
US3406023A (en) * 1966-10-31 1968-10-15 Du Pont Herbicidal method
US3954758A (en) * 1970-05-27 1976-05-04 Pcr, Inc. Process for fluorinating uracil and derivatives thereof
CH553195A (de) * 1971-03-19 1974-08-30 Sandoz Ag Verfahren zur herstellung neuer 2,6-dichlor-benzaldoximo-(s-triazinyl-(6))-aether.
US3987045A (en) * 1971-05-03 1976-10-19 Basf Aktiengesellschaft Disperse dyes based on isoindolene derivatives
US3954759A (en) * 1972-07-13 1976-05-04 Pcr, Inc. Process for preparation of 6-substituted 5-fluorouracil derivatives
DE2401619C2 (de) * 1974-01-14 1986-04-03 Kailash Kumar Prof. Dr. 2359 Lentföhrden Gauri Fungistatisch wirksame Uracilderivate und Verfahren zu ihrer Herstellung
FR2298332A1 (fr) * 1975-01-22 1976-08-20 Asahi Chemical Ind Nouveaux derives de 5-fluorouraciles
US4071519A (en) * 1975-11-05 1978-01-31 Mitsui Toatsu Chemicals, Incorporated 1-Carbamoyl-5-fluorouracil derivatives
US4080455A (en) * 1975-12-16 1978-03-21 Taisho Pharmaceutical Company Limited 5-Fluoropyrimidin-4-one compositions

Also Published As

Publication number Publication date
PT66374B (en) 1978-08-25
DK142029C (nl) 1981-01-05
PH14553A (en) 1981-09-24
DD137353A5 (de) 1979-08-29
CA1081226A (en) 1980-07-08
FR2346337B1 (nl) 1983-05-13
PT66374A (en) 1977-04-01
NO771124L (no) 1977-10-03
GR68935B (nl) 1982-03-29
DE2714392A1 (de) 1977-12-22
PL197045A1 (pl) 1978-02-13
FI770904A (nl) 1977-10-01
DD132790A5 (de) 1978-11-01
NL7703541A (nl) 1977-10-04
ES469098A1 (es) 1979-09-16
US4329460A (en) 1982-05-11
DK142029B (da) 1980-08-11
GB1546346A (en) 1979-05-23
PL106917B1 (pl) 1980-01-31
SU795467A3 (ru) 1981-01-07
FR2346337A1 (fr) 1977-10-28
DK141177A (nl) 1977-10-01
CH632748A5 (de) 1982-10-29

Similar Documents

Publication Publication Date Title
SE435059B (sv) Forfarande for framstellning av med kveveheterocykliska grupper substituerade 1-fenyl-2-alkylaminoetanol-foreningar
SE434395B (sv) Analogiforfarande for framstellning av karbostyrilderivat med terapeutisk verkan
SE7805591L (sv) Forfarande for framstellning av aminoalkylbensen-derivat med farmaceutisk verkan
NO144848C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme 4-hydroksyfenylalkanolamin-derivater
NO143992C (no) Fremgangsmaate for fremstilling av heksanitrostilben
SE429338B (sv) Forfarande for framstellning av substituerade 2-bensylpyrrolidiner med terapeutisk verkan
SE411671B (sv) Forfarande for framstellning av tripeptidderivat med terapeutisk verkan
SE434263B (sv) Forfarande for framstellning av kloretylnitrosokarbamider med antitumorverkan
SE7804736L (sv) Forfarande for framstellning av isoindolinderivat med terapeutisk verkan
SE7703721L (sv) Forfarande for framstellning av hexahydroprimidinforeningar med terapeutisk verkan
SE7514308L (sv) Forfarande for framstellning av tyrosinderivat med terapeutisk verkan
NO793447L (no) Fenyl-lavere-alkanoylaminer for bruk til fremstilling av terapeutisk virksomme forbindelser
SE7600343L (sv) Forfarande for framstellning av ferrocenderivat med terapeutisk verkan
SE435380B (sv) Forfarande for framstellning av kinazolinforeningar
SE7608538L (sv) Forfarande for framstellning av substituerade fenylalkylaminoalkylbensenderivat med terapeutisk verkan
SE7507887L (sv) Forfarande for framstellning av bensopyranforeningar med terapeutisk verkan.
SE7608115L (sv) Forfarande for framstellning av kinoxalinderivat med terapeutisk verkan
SE7805105L (sv) Forfarande for framstellning av pyranokinolinderivat med terapeutisk verkan
SE7712219L (sv) Forfarande for framstellning av trans-5a-aryl-dekahydrobenzazpiner med terapeutisk verkan
SE7713839L (sv) Forfarande for framstellning av indanderivat med terapeutisk verkan
SE7708521L (sv) Forfarande for framstellning av aminoalkylfuranderivat med terapeutisk verkan
SE7606236L (sv) Forfarande for framstellning av piperazinforeningar med terapeutisk verkan
NO774147L (no) Fremgangsmaate for fremstilling av kinazolinonforbindelser
SE417712B (sv) Forfarande for framstellning av n-(6-acyloxibensotiazol-2-yl)-nŸ-fenylkarbamider med terapeutisk verkan
SE7712217L (sv) Forfarande for framstellning av dekahydrocyklopent-(c)azepiner med terapeutisk verkan